Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon patents superoxide dismutase mimics for optic nerve and retinal damage

Sep. 15, 2005

Genentech targets Lucentis BLA filing for December

Sep. 9, 2005

Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease

Sep. 9, 2005

Recent Allergan patent reports new treatments for glaucoma

Sep. 7, 2005

Isis grants iCo license for ISIS-13650 for eye diseases

Aug. 29, 2005

Nevanac approved for pain and inflammation related to cataract surgery

Aug. 25, 2005

Akorn signs agreement for AK-1015

Aug. 18, 2005

Novel antiglaucoma agents jointly disclosed by Ube and Santen

Aug. 18, 2005

TargeGen selects TG-100801 for clinical development

Aug. 2, 2005

Progress in NicOx ophthalmology collaboration with Pfizer

July 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...